You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Sodium zirconium cyclosilicate for treating hyperkalaemia

  • Technology appraisal guidance
  • Reference number: TA1148
  • Published:  29 April 2026
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence

  • Evaluation report

  • Draft guidance consultation committee papers (TA1148) (PDF 4.2 MB)

    Published:
    29 April 2026
  • Final draft guidance committee papers (TA1148) (PDF 1.48 MB)

    Published:
    29 April 2026
  • Draft guidance consultation 1 committee papers (TA599) (PDF 4.76 MB)

    Published:
    04 September 2019
  • Draft guidance consultation 2 committee papers (TA599) (PDF 1.68 MB)

    Published:
    04 September 2019
  • Final draft guidance committee papers (TA599) (PDF 1.51 MB)

    Published:
    04 September 2019
  • Evidence review

  • TA599 Sodium zirconium cyclosilicate for treating hyperkalaemia: committee discussion

Back to top